DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through notch hyper-activation

The acquisition of endocrine therapy resistance in estrogen receptor α (ERα) breast cancer patients represents a major clinical problem. Notch signalling has been extensively linked to breast cancer especially in patients who fail to respond to endocrine therapy. Following activation, Notch intracel...

Descripción completa

Detalles Bibliográficos
Autores principales: Faronato, Monica, Nguyen, Van T.M., Patten, Darren K., Lombardo, Ylenia, Steel, Jennifer H., Patel, Naina, Woodley, Laura, Shousha, Sami, Pruneri, Giancarlo, Coombes, R. Charles, Magnani, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673176/
https://www.ncbi.nlm.nih.gov/pubmed/26093085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673176/
https://www.ncbi.nlm.nih.gov/pubmed/26093085

Ejemplares similares